Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced the...
Axon Therapies, a private company focused on addressing a root cause of heart failure, announced positive early results from a roll-in cohort for their...
TytoCare, the global healthcare industry's first all-in-one modular device and examination solution for AI-powered, remote medical exams, is announcing today a partnership with Rochester...
iOnctura SA, a clinical stage oncology company targeting core resistance and relapse mechanisms at the tumor-stroma-immune interface, announces it will present clinical and preclinical...
